GlassScriptPhysician profile
Jason Cohen
NPI 1205268125
$36,161.43
in general payments reported to CMS, 2019-2025
28 companies · $7,255 in 2025
The $7,255 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $15K · 2021: $843 · 2022: $3,832 · 2023: $3,102 · 2024: $5,657 · 2025: $7,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,893 · Travel and Lodging: $6,050 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,893.43 |
| Travel and Lodging | $6,049.51 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $12,771.85 | 2019-2020 | |
| Abbott Laboratories | $10,335.31 | 2019-2025 | Aveir, Amplatzer Amulet, Ensite |
| Medtronic, INC. | $5,420.65 | 2021-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $5,413.99 | 2019-2025 | Farapulse, Watchman, Ekosonic |
| E.R. Squibb & Sons, L.L.C. | $459.53 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $259.77 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Edwards Lifesciences Corporation | $223.09 | 2021-2024 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.30 | 2019-2025 | Lifevest |
| Terumo Medical Corporation | $147.91 | 2023-2024 | Azur Cx Detachable, Glidewire |
| Novartis Pharmaceuticals Corporation | $135.79 | 2019-2025 | |
| Genzyme Corporation | $122.88 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $112.39 | 2021 | |
| Sanofi-Aventis U.S. LLC | $100.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $99.25 | 2019 | |
| Lantheus Medical Imaging, INC. | $57.67 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.69 | 2023-2024 | Jardiance |
| Pfizer INC. | $49.70 | 2023 | |
| Biosense Webster, INC. | $37.69 | 2019-2021 | |
| Amgen INC. | $30.49 | 2019 | |
| Cvrx, INC. | $28.75 | 2022 | |
| Merck Sharp & Dohme LLC | $23.47 | 2023 | Verquvo |
| W. L. Gore & Associates, INC. | $22.87 | 2024 | Gore Cardioform Septal Occluder |
| Regeneron Healthcare Solutions, INC. | $22.34 | 2019 | |
| Cordis US Corp. | $19.37 | 2025 | Mynx Control Venous |
| Portola Pharmaceuticals, LLC | $18.75 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.39 | 2019 | |
| Irhythm Technologies, INC. | $17.47 | 2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.